BCL6 and neoplasm: Critically, FLLL31 exhibits enhanced bioavailability and metabolic stability relative to parental curcumin, enabling selective tumor cytotoxicity via coordinated upregulation of FOXO4, activation of BCL6, and suppression of Bcl‐xL‐mediated mitochondrial apoptotic inhibition.